Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 EP699 | DOI: 10.1530/endoabs.99.EP699

1Department of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medecine and Pharmacy, University of Mohammed 1st, Oujda, Morocco, oujda, Morocco; 2Department of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medecine and Pharmacy, University of Mohammed 1st, Oujda, Morocco, Laboratory of Epidemiology, Clinical Research and Public Health, Mohammed VI University Hospital Center, Faculty of Medecine and Pharmacy, University of Mohammed 1st, Oujda, Morocco, Oujda, Morocco


Introduction: Micropenis represents a diagnostic and therapeutic challenge. The Diagnosis is based on the measurement of penile length. Defined by normal structure, abnormal size: -2 standard deviation (SD) below of average of age. The aim of our study is to evaluate the etiological profile and therapeutic efficacy.

Patients and methods: It’s a retrospective and descriptive study including 55 childrens and adolescents with micropenis, treated with hormonal therapy followed up in the Department of Endocrinology-Diabetology and Nutrition of Mohammed VI University, Hospital Center, Oujda, in Morrocco, between 2014 and 2023. All patients in our series were received a clinical examination including measurement of penis size, biological evaluation and bone age. The statistical analysis was done by SPSS version 21.

Results: The average age of our study group was 13±7 years. Forty-eights percent of the patients were the adolescents. The most frequent reasons for consultation were the Growth retardation (55%) then testicular abnormality (22%). The mean penile size is -2.40±0.41 SD. Nine percent of the patients have penis anomaly and 25% have testicule anomaly. The luteinizing hormone-releasing hormone (LHRH) test was performed in 38% of the patients. The exploration revealed that idiopathic micropenis is the most frequent etiology (29%), followed by growth hormone deficiency (21%). All patients of our group were put on hormonal treatment. The transdermal dihydrotestosterone was administred at 60% of the patients and 40% at the intramuscular injection of testoterone enanthate. The post treatement evaluation revealed that the mean penile size is -1.39±0.75 SD. Therapeutic efficacy was observed in 70% of patients (P<0.05).

Discussion and conclusion: The Early diagnosis of micropenis is based on a thorough clinical examination of all newborns and infants, for early and appropriate management. The most etiology of Micropenis is idiopathic but it is a diagnosis of elimination. The hormonal treatment is not always effective in the puberty, hence the importance of psychological support.

Key words: Micropenis -Growth Hormone- Testosterone Enanthate.

References: 1. Nihal, H., & Selim, K. (2013). Micropenis: Etiology, Diagnosis and Treatment Approaches. Journal of Clinical Research in Pediatric Endocrinology, 5(4), 217–223. doi:10.4274/jcrpe.11352. Stancampiano MR, Suzuki K, O’Toole S, Russo G, Yamada G, Faisal Ahmed S. Congenital Micropenis: Etiology And Management. J Endocr Soc. 2021 Nov 15;6(2):bvab172.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

Catherine Cardot (<1 min ago)
Drachuk Elizaveta (<1 min ago)

My recently viewed abstracts